E5 is the smallest transforming protein encoded by the human papillomaviruses (HPVs). It has been shown to promote anchorage-independent growth in established NIH 3T3 cells, an activity that is enhanced in the presence of epidermal growth factor (EGF). It is thought that this activity of E5 is brought about by an increase in the half-life of stimulated EGF receptors, possibly through the perturbation of receptor processing. Recent studies have also shown that E5 can co-operate with HPV-16 E7 to stimulate proliferation of primary rodent cells. Using haemagglutinin I epitope-tagged E5 proteins, we have compared the mitogenic activity of HPV-6 and HPV-16 E5. Both tagged proteins retain the ability to bind to the cellular 16 kDa H+-ATPase protein.
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In addition, both HPV-6 and HPV-16 E5 retain the ability to co-operate with E7 in primary rodent cells, although E5 is considerably more active than HPV-6 E5 in these mitogenic assays. Interestingly, transfection of a plasmid over-expressing c-Raf appears to be capable of functionally substituting for E5 in the co-mitogen assays. Polyclonal cell lines derived from baby rat kidney cells co-transfected with E7 and E5 genes continue to express both the E5 and E7 mRNA, although the level of E5 expression is very low and protein cannot be detected. These polyclonal fines appear to be immortal and in some cases demonstrate anchorage-independent growth, an activity which is enhanced by the addition of EGF.
Certain human papillomaviruses (HPVs) have been shown to be associated with the development of cervical dysplasia and carcinomas (Diirst et al., 1983) . HPV-6 DNA is found in genital warts and low grade cervical lesions whereas HPV-16 DNA is frequently found in high grade lesions and in carcinomas (Diirst et al., 1983; Gissmann et al., 1983) . The HPV-16 E6 and E7 genes are retained and expressed in cervical tumours (Schwarz et al., 1985; Smotkin & Wettstein, 1987; Androphy et al., 1987; Banks et al., 1987) and represent the major transforming genes of the virus (Matlashewski et al., 1987; Phelps et al., 1988; Storey et al., 1988; Storey & Banks, 1993) . In contrast, the HPV-16 E5 gene is often lost as a result of viral integration into the host genome (Schwarz et al., 1985; Yee et al., 1985) . However, in bovine papillomavirus type 1 (BPV-1) which has often been used as the prototype for HPV, E5 is the major oncogene (Schiller et al., 1984 (Schiller et al., , 1986 Yang et al., 1985; DiMaio et aL, 1986) . BPV-1 E5 and HPV E5 are both very hydrophobic proteins which attach to endomembranes and form a complex with the 16 kDa poreforming component (' 16K protein') of vacuolar ATPase (Conrad et al., 1993) . BPV-1 E5 forms a trimeric complex * Author for correspondence. Fax +39 40 226555.
with the 16K protein and the platelet-derived growth factor (PDGF) 13 receptor (Goldstein et al., 1992) . The oncogenic activity of BPV-1 E5 is mediated principally by growth factor receptors, in particular the PDGF [3 receptor (Petti et al., 1991; Petti & DiMaio, 1994) , although BPV-1 E5 can also co-operate with the EGF receptor, depending upon the cell type (Martin et al., 1989; Cohen et al., 1993) .
We have previously shown that HPV-16 E5 could stimulate proliferation of primary baby rat kidney (BRK) cells in the presence of HPV-16 E7 (Bouvard et al., 1994) . We were interested in investigating the activity of HPV-6 E5 in this assay and using these cell lines to investigate E5 protein expression. However, to overcome problems associated with the poor immunogenicity of the E5 protein when expressed as a bacterial fusion protein, we proceeded to tag E5 with a highly antigenic epitope of influenza virus haemagglutinin I peptide (HAI) for which a commercial antiserum (12CA5) was available (Wilson et al., 1984) . This method had been successfully used for BPV-1 E5 protein (Goldstein & Schlegel, 1990) and recently adopted for HPV-16 and HPV-6 E5 proteins (Conrad et al., 1993 which contains the human cytomegalovirus (HCMV) promoter, to generate pJ7f2.16E5H and pJ7f2.6E5H, respectively. Our first concern was to ensure that the epitope-tagged E5 proteins retained their conformation.
To investigate this we made use of the previously reported observation that E5 proteins can complex with the 16K protein component of vacuolar ATPases (Conrad et al., 1993) . The 16K H+-ATPase was cloned from HeLa cells by reverse transcription of total R N A to generate full-length cDNA for use as a template in PCR amplifications. Primers for nested PCR were synthesized using information from the published sequence of the human 16K H+-ATPase (Gillespie et al., 1991) . The final PCR amplification product (525 bp) was cloned into p G E M -3 Z f ( + ) and sequenced to confirm that it was the human 16K component of vacuolar H+-ATPase; there were no changes from the published sequence. HPV-6 and HPV-16 E5H tagged proteins were translated in vitro, either individually or with the 16K protein and complex formation was monitored by immunoprecipitation analysis using antibodies against the HA1 epitope. Appropriate antibody (2 pl of 12CA5 ascites fluid or 2 ~tl of pre-immune mouse serum) was added to the in vitro translation products, corresponding to equal amounts of protein, and left on ice for 1 h. Then 100 ~tl of a suspension (20 %) of Protein A-Sepharose CL-4B beads (Pharmacia) in E l a buffer (250 mM-NaC1, 0"1% NP40, 50 mM-HEPES pH 7) plus protease inhibitors were added to the antibody-antigen complex and rotated for 1 h at 4 °C. Following this, the Sepharose beads were pelleted, washed five times in E l a buffer and analysed by SDS-PAGE and autoradiography. The results obtained are shown in Fig. 1 . Both the HPV-6 E5H ( Fig. 1 (Goldstein & Schlegel, 1990; Conrad et al., 1993) . Not surprisingly, the sequence of the human 16K protein (Gillespie et al., 1991) is very similar to that of the bovine protein (Goldstein et al., 1991) . The human 16K protein is one amino acid longer and contains five additional amino acid changes when compared with the bovine 16K protein. Clearly, these differences do not affect the ability of E5 to complex with the 16K protein.
Since the binding of BPV-1 E5 to 16K correlates with the ability of E5 to promote cell transformation, our results are consistent with the observations that HPV-16 E5 can increase the proliferative capacity of human keratinocytes (Storey et al., 1992; Straight et al., 1993) and perturb E G F receptor processing in these cells (Straight et al., 1993) . The HPV-16 E7 gene can co-operate withfos or ras to transform primary baby mouse kidney (BMK) cells (Crook et al., 1988) and with ras to transform BRK cells (Storey et al., 1988) . Recently, we have shown that cooperation between the HPV-16 E7 and E5 genes can result in an increased proliferative capacity in primary BRK cells which is enhanced in the presence of E G F (Bouvard et al., 1994) . We were therefore interested in determining how HPV-6 E5 would compare with HPV-16 E5 in this proliferation assay. Primary BRK cells prepared from 9-day-old Wistar rats were co-transfected using the calcium phosphate co-precipitation method as described previously (Bouvard et al., 1994) with either pJ71"~. 16E5H or pJ7f2.6E5H together with pJ4f2.16E7 and pSV2-neo, and were selected using 350 ~tg/ml of G418. After 3 weeks the cells obtained were either fixed with formol saline and stained with Giemsa or were trypsinized and passaged to obtain polyclonal lines. The resulting G418-resistant colonies can be seen in Fig. 2 . Clearly, there are more colonies present in the cotransfections containing HPV-16 E5H and HPV-6 E5H than in the controls. However, as can be seen from c-raf 2 and from the series of assays shown in Table 1 it is apparent that HPV-16 E5H plus HPV-16 E7 is more mitogenic than the HPV-6 E5H plus HPV-16 E7 combination. These results indicate that HPV-16 E5H has a greater mitogenic potential than HPV-6 E5H. The co-mitogenic activity is, however, conserved between both the benign-and oncogenic-associated HPV types and suggests that this represents a conserved function which is related more to viral replication than to cell transformation.
As c-Raf has been shown to act downstream of ras (Smith et al., 1986) in signal transduction we decided to investigate whether c-Raf could substitute for E5 in the B R K proliferation assays. The c-rafgene was cloned into the plasmid p J 4~ (Wilkinson et al., 1988) and cotransfected with pJ4f~. 16E7 (Storey et al., 1988) into B R K cells. The results obtained are shown in Fig. 2 and Table 1 . Clearly, c-Raf appears to be able to co-operate with HPV-16 E7 in the B R K proliferation assay in a similar manner to HPV E5H. This further supports the hypothesis that E5 functions via a signal transduction mechanism.
Previously we have noted that individual colonies from these assays were not immortal as they could not be propagated; however, polyclonal pools of both E7 and E7 plus E5-transfected cells could be grown for several weeks (Bouvard et al., 1994) . Therefore, we proceeded to investigate whether the polyclonal pools of transfected cells containing either HPV-16 E7 plus HPV E5H or HPV E5H and HPV-16 E7 alone could be propagated indefinitely. Neither cells transfected with HPV-16 E5H nor with HPV-6 E5H alone could be propagated. In contrast, cells transfected with HPV-16 E7 alone, HPV-16 E7 plus HPV-16 E5H or HPV-6 E5H continued to grow. Cell line 1, containing HPV-16 E7 plus HPV-16 E5H, has been grown for 8 months and can be considered to be immortalized; cells containing HPV-16 E7 plus HPV-6 E5H and HPV-16 E7 alone have been growing in culture for 3 and 4 months, respectively, without senescence. It should be emphasized that in no case have we Short communication been able to isolate single, immortalized colonies, indicating that the E5 plus E7 interaction does not represent an efficient combination of co-operating oncogenes. Nevertheless, the proliferative capacity provided by these two genes allows changes to take place at sufficient frequency within the population for immortalized cell lines to be established.
In order to determine whether the E7 and E5 genes continue to be transcribed in the immortalized cell lines we investigated the levels of E7 and E5 m R N A expression. HPV-16 E7 mRNA was detectable by Northern blot analysis (Leechanachai et al., 1992) in all of the cell lines into which it had been transfected (Fig.  3a, b) . This was reduced in cell line 1 upon continual passage. No E5 mRNA was detectable by Northern blot analysis in any of the cell lines into which it had been transfected. To determine whether E5 mRNA was present, a more sensitive method was employed which consisted of reverse transcribing the total RNA extracted from the cells, amplifying this cDNA by PCR using primers specific for HPV E5H DNA and then analysing this amplified DNA by Southern blotting (Southern, 1975) . As can be seen in Fig. 3(c, d) , HPV-16 and HPV-6 E5H DNA could be amplified from cell lines containing HPV-16 E5H or HPV-6 E5H but not from control cell lines. The HPV-16 E5H cell lines which had previously been negative for E5 m R N A by Northern blot analysis were positive using this more sensitive method. Although HPV-6 E5H RNA can also be detected, the HPV-6 E5H amplified cDNA gave a much weaker signal than HPV-16 E5H with a probe specific for HPV-6 (Fig. 3d ). These results demonstrate that E5 continues to be expressed in the immortalized lines, albeit at very low levels. Unfortunately, we have not been able to detect E5 protein expression in these cells. The reasons for this are not clear, but the low level of RNA expression, even with the HCMV promoter, obviously contributes to the difficulties.
As E5 expression had been reported to increase the cellular response to serum growth factors (Leechanachai et al., 1992) we decided to examine the growth characteristics of our polyclonal cell lines derived from E5-plus E7-transfected primary BRK cells in high and low serum. The growth kinetics of these cell lines were also studied in the presence and absence of EGF, since we had previously observed that EGF could enhance the growth of cells co-transfected with HPV-16 E5 and E7. The polyclonal cell lines were seeded at 5 x 104 cells per 60 mm dish and grown in DMEM with or without EGF (25 ng/ml) and either 10 % or 1% FCS. Duplicate dishes were counted daily for 6 days. The cell lines used in these assays were obtained from primary BRK cells transfected with HPV-16 E5H plus HPV-16 E7 (lines 1 and 3), HPV-6 E5H plus HPV-16 E7 (line 4) and HPV-16 E7 alone (line 5). The results show clearly that, with the exception of cell line 1, none of the lines tested could grow in low serum (Fig. 4) . At the high serum concentration, cell line 1 grew to a higher saturation density (Fig. 4b) than the other lines, including the control line transfected with E7 alone (Fig. 4a) . Anchorage-independent growth of cells in soft agar can be used as a marker for the degree of cell transformation. In order to assess the level of transformation of our immortal BRK cell lines we examined their ability to grow in soft agar in both high and low serum concentrations and in the absence and presence of exogenous EGF (Table 2 ). The cell lines obtained from pooled G418-resistant colonies were seeded at a density of 1.5 x 104 cells per 60 mm dish into DMEM plus FCS with 0-4 % Noble agar, with or without EGF (25 ng/ml). Each experiment was carried out in duplicate and the dishes were scored for colony formation after 2-3 weeks. The typical loci formed in 10% FCS with and without EGF can be seen in Fig. 5 . From these results it is clear that line 1 grows well in soft agar and that growth is increased in the presence of EGF. In particular, line 1, which contains E5 and E7 sequences, is clearly more transformed than line 5, which contains only E7 sequences. In this case only 9 % of cells form colonies at passage 23 compared with 32% at a similar passage number for line 1. The other lines are at earlier passages but, with the exception of line 2, show increased growth in agar compared to control cells. Growth in agar is also dependent upon high serum concentration and, in most cases, EGF has a stimulatory effect. These results demonstrate that E5 and E7 can stimulate the proliferation of primary BRK cells, enhance immortalization and promote anchorage-independent growth, each of which can be augmented by the addition of EGF.
From the data presented here and elsewhere Straight et al., 1993; Bouvard et al., 1994) it is tempting to speculate that E5 plays a critical role in initiating viral replication by upregulating growth factor signal transduction to the nucleus when cells are in a suitable nutritional environment. This activity of E5 directly complements that of E7 which has previously been shown to be increased by certain growth factors (Morris et al., 1993) . It now remains to be seen whether these activities of E5 play a role in the early stages of malignant transformation, a possibility which cannot be excluded.
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